August 31, 2017Asia-Pacific Journal of Clinical Oncology97 citationsOpen Access

Strain‐specific probiotic (microbial cell preparation) and omega‐3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial

BGBabak GolkhalkhaliUniversity of Malaya RRRetnagowri RajandramUniversity of Malaya APAudra Shaleena PalianyUniversity of Malaya

Key Points

Key points are not available for this paper at this time.

Abstract

The combined supplementation with MCP and omega-3 fatty acid may improve quality of life, reduce certain inflammatory biomarkers and relieve certain side effects of chemotherapy in colorectal patients on chemotherapy.

Demander à l'IA

Bookmark

View Full Paper